IFNG and neoplasm: High IFN-γ gene expression signature and high tumor mutational burden (TMB) in pretreatment tumor biopsies were associated with a higher rate of pathological response and a lower risk of relapse, suggesting the potential as a predictive biomarker for neoadjuvant IO response.